Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 1551: A systematic review combines data from 15 randomized controlled trials studying the same intervention. What is the main advantage of this approach compared to individual studies?

A. It guarantees clinical applicability of results
B. It reduces the risk of publication bias to zero
C. It eliminates the need for statistical significance testing
D. It increases statistical power and precision of estimates (Correct Answer)

Explanation: ***It increases statistical power and precision of estimates*** - By combining data from multiple studies, **systematic reviews** and **meta-analyses** dramatically increase the overall sample size, which enhances the **statistical power** to detect a true effect if one exists. - This larger dataset also leads to **more precise estimates** of the intervention's effect, reducing the impact of random error present in individual studies. *It guarantees clinical applicability of results* - While systematic reviews provide strong evidence, **clinical applicability** (or external validity) is determined by how well the study population and intervention align with common clinical practice, which is not guaranteed by the review method itself. - Factors like patient heterogeneity, specific intervention protocols, and study settings can still limit the direct applicability of findings to all clinical scenarios. *It reduces the risk of publication bias to zero* - Systematic reviews can mitigate, but generally do not eliminate, **publication bias** (the tendency for studies with significant results to be published more readily). - While reviewers use comprehensive search strategies and sometimes include unpublished data, the complete absence of publication bias is difficult to achieve. *It eliminates the need for statistical significance testing* - **Statistical significance testing** remains a crucial component of systematic reviews and meta-analyses to determine the confidence in the combined treatment effect. - The pooled effect estimates are still subjected to statistical tests and confidence interval calculations to interpret the results meaningfully.

Question 1552: A cohort study follows 10,000 healthcare workers over 10 years to assess the relationship between shift work and cardiovascular disease. What is the main advantage of this study design?

A. It requires fewer participants than other designs
B. It can establish temporal relationships and calculate incidence (Correct Answer)
C. It can establish causation definitively
D. It is less expensive than other study designs

Explanation: ***It can establish temporal relationships and calculate incidence*** - **Cohort studies** follow individuals over time, allowing researchers to observe the sequence of events and confirm that the exposure (shift work) precedes the outcome (cardiovascular disease), thereby establishing a **temporal relationship**. - By following a group of individuals free of the disease at baseline and observing new cases that develop over time, **incidence rates** of the disease in exposed versus unexposed groups can be calculated. *It requires fewer participants than other designs* - **Cohort studies**, especially those investigating rare outcomes or long follow-up periods, often require a **large number of participants** to achieve sufficient statistical power. - Case-control studies or cross-sectional studies can sometimes achieve their objectives with **fewer participants**. *It can establish causation definitively* - While cohort studies are strong for establishing **temporal relationships** and identifying associations, they do not definitively "prove" causation due to the potential for residual confounding and other biases. - Establishing **causation** usually requires a body of evidence from various study designs and might be best addressed by randomized controlled trials where appropriate. *It is less expensive than other study designs* - **Cohort studies** are typically **expensive** due to the long follow-up periods, extensive data collection, and large sample sizes required. - They also involve significant logistical challenges and resource consumption for **participant tracking and data management**. *It eliminates all potential confounding variables* - While cohort studies can adjust for known **confounding variables** through design or statistical analysis, they cannot eliminate **all potential confounders**, particularly unknown or unmeasured ones. - All observational studies are susceptible to some degree of **residual confounding**.

Question 1553: A screening program for breast cancer uses mammography with 85% sensitivity and 90% specificity. In a population with 2% breast cancer prevalence, what percentage of positive test results will be false positives?

A. 10%
B. 15%
C. 98%
D. 83% (Correct Answer)

Explanation: ***83%*** - Approximately 83% of positive test results will be **false positives**. This is calculated by finding the overall proportion of positive tests (true positives + false positives) and then determining the percentage of false positives within that total. - Given a 2% prevalence, 0.017 true positives (0.02 × 0.85) and 0.098 false positives (0.98 × 0.10) occur. The total positive tests are 0.017 + 0.098 = 0.115. The false positive percentage is (0.098 / 0.115) × 100% = **85.2%**. This value is closest to 83%. Note: Slight numerical differences can arise from rounding. *10%* - This value likely reflects the **false positive rate** (1 - specificity = 1 - 0.90 = 0.10 or 10%) but not the percentage of positive test results that are false positives. - The false positive rate (1-specificity) refers to the proportion of healthy individuals who test positive, not the proportion of all positive tests that are false. *15%* - This value is related to the **false negative rate** (1 - sensitivity = 1 - 0.85 = 0.15 or 15%), which is not what the question is asking. - The false negative rate indicates the proportion of individuals with the disease who test negative. *98%* - This number represents the **prevalence of healthy individuals** (1 - prevalence of disease = 1 - 0.02 = 0.98 or 98%), which is used in the calculation but is not the answer itself. - It doesn't directly answer the question about the proportion of false positives among all positive tests.

Question 1554: A pharmaceutical company wants to test a new medication. They recruit 1000 healthy volunteers and randomly assign 500 to receive the medication and 500 to receive a placebo. Neither participants nor researchers know who receives which treatment. What type of study design is this?

A. Case-control study
B. Cohort study
C. Cross-sectional study
D. Double-blind randomized controlled trial (Correct Answer)

Explanation: ***Double-blind randomized controlled trial*** - This design involves **random assignment** to treatment or placebo groups, a hallmark of an RCT, and ensures that neither participants nor researchers know who received which treatment (**double-blind**). - This methodology **minimizes bias** and is considered the **gold standard** for establishing causality and evaluating the efficacy of new interventions. *Case-control study* - This study design **compares individuals with a disease/outcome (cases)** to individuals without it (controls) to look for past exposures. - It works **retrospectively**, looking back in time to identify exposures, which is different from the prospective intervention described. *Cohort study* - A cohort study **follows a group of individuals (a cohort)** over time to observe the development of disease or outcomes. - While prospective, it is primarily **observational** and does not involve the active intervention and random assignment of a new medication. *Cross-sectional study* - This type of study **measures exposure and outcome simultaneously** at a single point in time, providing a "snapshot" of a population. - It cannot establish **causality** or the effect of an intervention over time due to its single-point assessment.

Question 1555: A researcher wants to study the relationship between smoking and lung cancer. She identifies 500 patients with lung cancer and 500 controls without lung cancer, then investigates their smoking history. What type of study design is this?

A. Cross-sectional study
B. Case-control study (Correct Answer)
C. Cohort study
D. Randomized controlled trial

Explanation: ***Case-control study*** - This study design **compares individuals with a disease (cases) to individuals without the disease (controls)** and retrospectively examines their exposure to risk factors. - The researcher identified patients with lung cancer (cases) and those without (controls) and then looked back at their smoking history (exposure). *Cross-sectional study* - A **cross-sectional study** assesses both exposure and outcome simultaneously at a single point in time. - It provides a snapshot of the prevalence of an outcome and associated factors but cannot establish causality. *Cohort study* - A **cohort study** follows a group of individuals (cohort) over time to see who develops the disease based on their initial exposure status. - It starts with exposed and unexposed groups and tracks them forward to observe disease incidence. *Randomized controlled trial* - A **randomized controlled trial (RCT)** involves random assignment of participants to different intervention groups, including a control group. - RCTs are used to test the effectiveness of interventions and are prospective in nature, not retrospective.

Question 1556: In demographic transition analysis, what does the difference between birth rates and death rates represent when plotting demographic changes over time?

A. Birth rate
B. Death rate
C. Natural increase (Correct Answer)
D. Growth Rate

Explanation: ***Natural increase*** - **Natural increase** is specifically defined as the difference between the **birth rate** and the **death rate** in a population. - When plotted over time in demographic transition models, this difference visually represents the **population growth** or decline due to births and deaths alone, excluding migration. *Birth rate* - The **birth rate** is the number of live births per 1,000 people in a given year. - It is only one component of the calculation for natural increase, not the difference itself. *Death rate* - The **death rate** is the number of deaths per 1,000 people in a given year. - It is another component used to calculate natural increase but does not represent the difference between the two rates. *Growth Rate* - The **growth rate** of a population usually includes the effects of both **natural increase** (births minus deaths) and **net migration** (immigration minus emigration). - While natural increase contributes to the overall growth rate, it specifically refers to the growth stemming only from births and deaths, without considering migration.

Question 1557: What is the period called between the entry of an organism into the host and the point of maximum infectivity?

A. Generation Time
B. Incubation Period
C. Latent Period (Correct Answer)
D. Prodromal Period

Explanation: ***Latent Period*** - The **latent period** is the time from entry of an organism into the host until the host becomes **infectious** (able to transmit the disease to others). - During this phase, the organism replicates within the host, but the host is not yet shedding sufficient pathogen to transmit infection. - This period ends when the host begins to shed the pathogen and can transmit it to susceptible individuals, which often coincides with peak infectivity in many diseases. - The latent period is crucial in epidemiology for understanding disease transmission dynamics and implementing control measures. *Generation Time* - **Generation time** (or serial interval) in epidemiology refers to the time interval between the onset of infection in a primary case and the onset of infection in a secondary case. - It reflects the average time between successive generations in a chain of transmission. - This is distinct from the latent period and does not specifically address the period until infectivity begins. *Incubation Period* - The **incubation period** is the time between exposure to an infectious agent and the **onset of clinical symptoms**. - It may overlap with or differ from the latent period; some diseases are infectious before symptoms appear (e.g., measles, chickenpox), while others become infectious only after symptoms develop. - The incubation period does not directly correlate with the timing of infectivity. *Prodromal Period* - The **prodromal period** occurs after the incubation period and is characterized by the appearance of **early, nonspecific symptoms** (e.g., malaise, fever, fatigue). - These symptoms precede the characteristic manifestations of the disease. - During the prodromal period, the person may already be infectious, but this period is defined by symptom characteristics, not infectivity timing.

Question 1558: The incubation period of a disease is 5-14 days. What should be the quarantine period?

A. 5 days
B. 10 days
C. 14 days (Correct Answer)
D. 20 days

Explanation: ***14 days*** - The **quarantine period** should be equal to or slightly longer than the **maximum incubation period** of the disease. - In this case, 14 days covers the entire potential incubation range of 5-14 days, ensuring any exposed individual would develop symptoms within this period if infected. *5 days* - A 5-day quarantine period is too short as it is equal to the **minimum incubation period** and would not capture individuals with longer incubation times. - An individual could become symptomatic and transmit the disease after the 5-day quarantine if their incubation period was longer. *10 days* - A 10-day quarantine period is insufficient as it falls short of the **maximum incubation period** of 14 days. - An individual could still develop symptoms and become infectious up to 4 days after completing a 10-day quarantine. *20 days* - A 20-day quarantine period is unnecessarily long as it exceeds the **maximum incubation period**. - While it ensures coverage of the incubation period, it imposes excessive burden and resource utilization without added public health benefit.

Question 1559: Which of the following diseases has the largest submerged portion in the iceberg model of disease?

A. Influenza (Correct Answer)
B. Chickenpox
C. Tetanus
D. Rabies

Explanation: **The Iceberg Model of Disease** represents the concept that for many diseases, only a small portion of cases (the "tip" above water) are clinically apparent and reported, while a much larger portion (the "submerged" part) consists of asymptomatic, subclinical, or undiagnosed cases. ***Influenza*** - Has the **largest submerged portion** among the given options, with **50-75% of infections being asymptomatic or mild** and going undiagnosed - High transmissibility and varied clinical presentation contribute to significant hidden burden - Only severe cases requiring hospitalization typically get reported, representing just the "tip of the iceberg" - Classic example of diseases with large subclinical-to-clinical ratio *Chickenpox* - Most cases are **clinically apparent** with characteristic vesicular rash - Asymptomatic infections are rare due to distinctive clinical features - High visibility of cases reduces the submerged portion significantly *Tetanus* - **Severe, acute neurological condition** with distinct clinical manifestations (trismus, risus sardonicus, opisthotonus) - Almost all cases are diagnosed due to dramatic presentation - Virtually no submerged portion - what exists clinically is recognized *Rabies* - **Nearly uniformly fatal** once symptoms appear, making all symptomatic cases clinically evident - No asymptomatic or mild phase after symptom onset - Minimal to no submerged portion in the iceberg model

Question 1560: There is an outbreak of buboes in a community. What is the vector responsible for transmitting the causative agent?

A. Human flea
B. Sand fly
C. Xenopsylla [Rat Flea] (Correct Answer)
D. Tsetse fly

Explanation: ***Xenopsylla [Rat Flea]*** - The presence of **buboes** is characteristic of the **bubonic plague**, caused by *Yersinia pestis*. - *Xenopsylla cheopis*, the **rat flea**, is the primary **vector** responsible for transmitting *Yersinia pestis* from rodents to humans. *Human flea* - While human fleas (*Pulex irritans*) can bite humans, they are not the primary or most efficient vector for transmitting **bubonic plague**. - Their role in widespread outbreaks is generally considered minor compared to the **rat flea**. *Sand fly* - **Sand flies** are vectors for diseases such as **leishmaniasis** and **sandfly fever**. - They are not associated with the transmission of **bubonic plague** or the formation of **buboes**. *Tsetse fly* - The **tsetse fly** is the vector for **African trypanosomiasis** (sleeping sickness). - This disease presents with fevers, headaches, and neurological symptoms, not **buboes**.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free